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Mass or Turnover, in a Group of Australian
Aged Care Residents
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In residential care, inadequate calcium and folate intakes and low
serum vitamin D (25(OH)D) concentrations are common. We
assessed whether daily provision of calcium, folate, and vitamin
D3–fortified milk for 6 months improved nutritional status (serum
micronutrients), bone quality (heel ultrasound), bone turnover
markers (parathyroid hormone, C-terminal collagen I telopeptide,
terminal propeptide of type I procollagen), and=or muscle strength
andmobility in a group of Australian aged care residents. One hun-
dred and seven residents completed the study (mean (SD) age: 79.9
(10.1) years; body weight: 68.4 (15.4) kg). The median (inter-
quartile range) volume of fortified milk consumed was 160
(149)ml=day. At the end of the study, the median daily vitamin
D intake increased to 10.4 (8.7) lg (P< .001), which is 70% of
the adequate intake (15lg); and calcium density (mg=MJ) was
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higher over the study period compared with baseline (161 5mg=MJ
vs. 142 4mg=MJ, P< .001). Serum 25(OH)D concentrations
increased by 23 2nmol=L (83 (107)%, P< .001), yet remained
in the insufficient range (mean 45 2nmol=L). Consumption of
greater than the median intake of milk (160ml=day) (n¼ 54,
50%) increased serum 25(OH)D levels into the adequate range
(53 2nmol=L) and reduced serum parathyroid hormone by 24%
(P¼ .045). There was no effect on bone quality, bone turnover mar-
kers, muscle strength, or mobility. Consumption of fortified milk
increased dietary vitamin D intake and raised serum 25(OH)D con-
centrations, but not to the level thought to reduce fracture risk. If
calcium-fortified milk also was used in cooking and milk drinks, this
approach could allow residents to achieve a dietary calcium intake
close to recommended levels. A vitaminD supplement would be recom-
mended to ensure adequate vitamin D status for all residents.
KEYWORDS aging, calcium, milk, residential care, vitamin D
INTRODUCTION
It is well established that many older people in residential care are
consuming inadequate amounts of energy and both macro- and micronutri-
ents (1–6). Low intakes of calcium and vitamin D have been implicated in the
development of osteoporosis and fracture (7). Vitamin D status is primarily
determined by sunlight exposure. As elderly individuals in residential care
seldom go outside (8) and few foods contain significant amounts of vitamin
D, a high rate of vitamin D deficiency is often observed (9–11).
There is conflicting evidence regarding the impact of vitamin D or
calcium treatment alone on bone and fractures (12–16). However, supple-
mentation studies that have increased dietary vitamin D intakes have been
found to reduce rates of fracture when the vitamin D is complemented
with calcium supplements (17–19). Dietary folate intakes also tend to be
low in aged care residents (4), and there is conflicting evidence regarding
folate supplementation and its effects on bone (20, 21) and fracture (22,
23). We have previously reported that six months of multivitamin supple-
mentation that included calcium, vitamin D, and folate (200mg) improved
heel ultrasound in aged care residents (24). Nutrient intakes can be
increased with supplements; however the provision of nutrient-fortified
foods could provide a more sustainable way to maintain adequate nutrient
intake in older people. Taking supplements represents an added time and
cost burden for those residents already consuming numerous tablets each
day, thus compliance with calcium supplementation in the long-term is
poor (25).
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Therefore, fortification of the food supply offers an alternative, less
intrusive approach to increasing micronutrient intakes in older adults. Milk
fortified with vitamin D increased serum 25(OH)D levels after three months
in a residential care setting (26), and consumption of folate fortified milk for
six months increased serum folate levels (27). Among community-dwelling
older persons in Mexico, dietary folate intakes increased by approximately
22% following the fortification of enriched grain products (28), and among
Australian community dwelling older men, 400ml milk fortified with calcium
(1000mg) and vitamin D (40mg) improved serum 25(OH)D levels and bone
density when administered over two years (29). To date no studies have
assessed the impact of food fortification on nutritional status and risks factors
for fracture in Australian residential care.
Therefore, the aim of the current study was to determine whether
consumption of milk fortified with calcium, vitamin D, and folate for six
months improves nutrient intake, nutritional status, parathyroid hormone
(PTH), bone turnover, quantitative heel ultrasound (QUS), falls, timed up
and go (TUG) speed, and hand grip strength (HGS) in a group of Australian
aged care residents.
Subjects and Methods
Barwon Health is Victoria’s largest regional health care provider. It provides
758 inpatient beds, with the aged care facility providing 260 high-level care
(HLC) nursing home beds and 106 low-level care (LLC) hostel beds. HLC
residents require more assistance with feeding, are less mobile, and have a
higher dependency in daily living activities compared with those in LLC.
A total of 287 residents or their next-of-kin (if cognitively impaired)
were approached to participate in the study. Exclusion criteria were those
on percutaneous endoscopic gastrostomy feeds, dementia with aggressive
behaviors, or terminal frailty. All studies and experimental procedures for this
project were approved by the Human Research Ethics Committees of Barwon
Health and Deakin University.
Intervention
The study was a six-month (December–June), longitudinal, single group
intervention assessing the effects of a daily supply of full cream containing
190mg calcium, vitamin D (cholecalciferol, 5 mg), and folate (75 mg) per
100ml. The fortified milk was developed by Murray Goulburn (Murray
Goulburn Co-op Ltd, Australia) to provide the maximum concentration of
calcium in the smallest volume, within the limits of the technology utilized.
A vitamin D dose of 5mg=100mls was chosen because this was estimated
to raise the average intake of vitamin D to approximately the adequate intake
level (AI) of 10mg=day (aged 50–70 years), while minimizing the risk of
238 J. A. Grieger and C. A. Nowson
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participants reaching intakes above the upper limit of 80 mg=day. The amount
of folate added to the milk was designed to take the average intake above the
Recommended Dietary Intake of 400mg=day (30).
The fortified milk developed for the study was manufactured and
provided in one liter cartons for use in tea, coffee, milk drinks, and on
cereal=porridge. The supply of milk to the participating residents was left
up to the discretion of the aged care nursing staff. However a trained inves-
tigator visited the HLC wards and LLC hostels each week to encourage staff to
use the milk in these food and drinks as well as to encourage cognitively
aware residents to increase its consumption. Based on previous observations
at the aged care facility, we estimated the mean intake of milk in beverages
and on breakfast cereals would be approximately 210ml=day.
Study Measurements
WEEKLY MILK INTAKE REPORTS
For each participant, a weekly milk audit was completed by a trained
investigator, estimating the volume of fortified milk consumed as a drink,
with cereal or porridge, or included in beverages. Information was
self-reported by 12 LLC residents to the investigator; and the remaining
estimates were received from the kitchen staff in HLC and LLC.
MEDICAL RECORDS
Three trained investigators were responsible for collecting information on
dietary requirements, mobility levels, current body weight, medications,
and medical diagnoses from residents’ medical records.
ANTHROPOMETRY
At baseline, stature height was calculated by measuring knee height (cm)
using sliding callipers (Shapers, Coffs Harbour, NSW, Australia) on either
leg while seated (10). Height was used with body weight to calculate body
mass index (BMI, kg=m2). The BMI reference ranges used were: <20 kg=m2
underweight; 20.0< 25.0 kg=m2 acceptable, >25.0 to<30.0 kg=m2 over-
weight, and 30.0 kg=m2 obese (31).
INDIVIDUAL DIETARY ASSESSMENT
Three trained research assistants assessed 24 hr dietary intakes on all
available participants at the following time points: baseline: (n¼ 115); either
week 11 (n¼ 54) or 18 (n¼ 53), and at the end of study (n¼ 107). By study
completion, each participant had a 24 hr dietary intake measurement, for a
total of three occasions. The validated visual plate waste method (32) was
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used to record food waste remaining after each main- and mid-meal and for
each item of food served. Drink waste was continually monitored until the
next main meal. The amount of food wasted was compared with the amount
served; therefore actual dietary intake was assessed from main meals and
mid-meals. Photographs of all standard food menu items had been
previously taken and were used as a guide for the estimated waste. The Food-
Works database (version 4, Xyris Software, Brisbane, Australia) was used to
calculate energy and nutrient intake. Dietary intakes of calcium, vitamin D,
and folate were compared with Australian Dietary Reference Intakes (30).
SERUM ASSAYS
A single blood sample (following8 hr fast) was taken at the beginning and at
the end of the study for measurement of serum calcium, 25(OH)D, folate,
parathyroid hormone (PTH), C-terminal collagen I telopeptide (CTX), and
terminal propeptide of type I procollagen (PINP). Serum calcium and albumin
were assayed using a Randox Daytona automated clinical chemistry analyzer
(Antrim, UK, 2002). High calcium levels were defined as serum concentrations
higher than 2.65mmol=L (33). Serum calcium was corrected for serum albu-
min using the formula: corrected Ca¼ total Caþ 0.02 (40-albumin). Radioim-
munoassays were used to measure serum 25(OH)D (DiaSorin Inc, Minnesota,
USA) and serum folate and vitamin B12 (BioRad Laboratories, NSW, Australia)
concentrations. The interassay CVs for serum 25(OH)D and folate was 11.1%
and 5.4%, respectively. Serum intact PTH [hPTH(1–84)] was measured by an
immunoradiometric assay (IRMA) using the DiaSorin N-tact PTH IRMA kit
(DiaSorin, Stillwater, MN, USA), and the interassay CV was 7.9%. C-terminal
collagen I telopeptide (CTX) was measured using an enzyme-linked immuno-
absorbance assay (Nordic Bioscience Diagnostics, Victoria, Australia); and
terminal propeptide of type I procollagen (PINP)wasmeasured using a standard
radio-immuno assay (Australian Laboratory Services, NSW, Australia), with an
interassay CV of 6.4% and 8.8%, respectively. All serum samples were
sub-aliquoted and stored at 80C until assayed. All assays were performed
in duplicate, and each subject’s samples were assessed in the same batch.
QUANTITATIVE HEEL ULTRASOUND
At the beginning and at the end of the study, quantitative heel ultrasound
(QUS) was reported using the broadband ultrasonic attenuation value
((dB=MHz); McCue Ultrasonics, CUBA Clinical, Winchester, UK).
FALLS INCIDENCE
Medical diagnosis of osteoporosis and having a history of falls were collected
from the medical records at the beginning of the study. For each participant,
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falls incidence was documented over the six-month study period by the
nursing staff and were recorded in the medical history. At the end of the
study, each participant’s medical history was reviewed by research staff
and the data on falls was extracted.
TIMED UP AND GO AND HAND GRIP STRENGTH
At the beginning and at the end of the study, the timed up and go (TUG) test
and hand grip strength (HGS) were assessed using standard methodological
approaches outlined previously (10).
ACCEPTABILITY QUESTIONNAIRE
At the end of the six-month study, a single questionnaire was administered
to a sub-sample of willing staff (as chosen by a study investigator) and
cognitively aware participants (who also completed a previous multi-
vitamin vs. placebo study [24]) to assess the acceptability of mode and
ease of utilizing the fortified milk. Staff completed self-administered
questionnaires that focused on their view of participant acceptability
and the degree of difficulty in administering the fortified milk to partici-
pants. Responses were in the form of a 10-point scale, with 1 indicating
‘‘not at all satisfied’’ or ‘‘not at all difficult’’ and 10 indicating ‘‘extremely
satisfied’’ or ‘‘extremely difficult.’’ A trained research assistant interviewed
the participants, whose questionnaire assessed the degree of difficulty in
incorporating the fortified milk into their everyday diet and their general
like or dislike of the taste of the milk. Staff and participants could also
make optional comments. For the current analysis, scores between 1
and 3 were grouped as ‘‘not at all satisfied’’ or ‘‘not at all difficult’’;
scores between 4 and 7 were grouped as ‘‘no opinion’’; and scores
between 8 and 10 were grouped as ‘‘extremely satisfied’’ or ‘‘extremely
difficult.’’
Statistical Analyses
Statistical analysis was performed using SPSS for Windows (SPSS Inc.,
Chicago, Illinois, Release 12.0.1). Descriptive data is represented as mean
(Standard Deviation [SD] or  Standard error [SEM]) or median (Interquar-
tile range [IQR]). Student’s t tests, chi square (v2) tests, and the univariate gen-
eral linear model analysis were used where appropriate. Skewed data was
log 10 transformed to achieve a normal distribution. Log 10 data was used
for all analyses; accordingly the geometric means were reported in the text.
We had 80% power to detect a 7.7 nmol=L change in serum 25(OH)D. The
alpha level for significance was set at P< .05.
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RESULTS
Study Participants
A total of 287 residents were invited to participate in the study. Fifty one
residents were interested and signed the consent form, and for those unable,
their next of kin gave proxy consent (n¼ 75). Before the study started, four
residents moved to an external facility, one resident was too frail to include,
and one resident died. One hundred and twenty residents began the study;
however four residents moved facility and four died, leaving 107 residents
(61% female) to complete the study (Table 1).
There was no difference in body weight or BMI at any time point
between HLC (n¼ 70) and LLC (n¼ 37) participants; however over the
six-month study participants in HLC had a mean loss of body weight com-
pared with a gain in LLC participants (1.0 0.4 kg vs. þ0.5 0.5 kg,
P¼ .024). Participants who took a vitamin D supplement with or without
calcium had a higher baseline serum 25(OH)D concentration compared
with those who did not take a vitamin D supplement (with=without
TABLE 1 Descriptive Data Mean (SD) for Those Who Completed the Study (n¼ 107) at
Baseline and Six Months
Baseline Six months
Age (years) 79.9 (10.1)
Body weight (kg) 68.4 (15.4) 67.7 (16.1)
BMI (kg=m2) 26.7 (5.6) 26.8 (6.8)
Mobility
Independent 18% 18%
With assistance 42% 37%
Immobile 40% 45%
Diet type
Normal 60% 64%
Diabetic 20% 14%
Low fat=reduction 12% 10%
High protein=high energy 6% 8%
Supplementsa
Calcium=vitamin D 15 (13%) 15 (13%)
Other multivitamins 29 (24%) 29 (24%)
Serum (n¼ 106)
Albumin (g=L) 38.7 (4.2) 38.2 (4.3)
25(OH)D (nmol=L)b 23.3 (23.7) 46.0 (28.8)y
Folate (nmol=L)b 13.4 (19.7) 17.9 (18.1)
PTH (pmol=L)b 3.1 (2.3) 3.2 (2.4)
Calcium (mmol=L)c 2.4 (0.2) 2.4 (0.2)
aThe same subjects took these medications at baseline and at the end of the study.
bRepresents median [inter-quartile range] as data was not normally distributed.
cCorrected for serum albumin.
vs. baseline (P¼ .030).
yvs. baseline (P< .001).
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calcium: 51.2 2.9 nmol=L (n¼ 15) vs. 26.5 1.6 nmol=L (n¼ 91), P< .001).
There was no difference in serum 25(OH)D between these groups at the end
of the study, respectively (50.6 4.4 nmol=L vs. 44.2 2.0 nmol=L, P¼ .228).
All participants who began on a supplement continued it throughout the
entire study period.
Fortified Milk Intake
The median (IQR) daily volume of fortified milk consumed over the
six-month study period was 160 (149) ml (range: 0–898ml; mean [SD] intake
over whole study: 178 [132] ml). Based on log transformed data, the mean
intake of fortified milk was significantly higher in HLC compared with LLC
(195 17ml [n¼ 70] vs. 147 17ml [n¼ 37] P¼ .039). There was no differ-
ence in intake between males and females (202 26ml [n¼ 42] vs.
163 12ml [n¼ 65] P¼ .334), respectively. Four participants (4%) con-
sumed no fortified milk as they drank black tea=coffee or did not eat cereal
or porridge at the breakfast meal. There was no difference in the estimated
volume of milk consumed at the beginning or end of the study
(211 16ml vs. 196 15ml, P¼ .332), respectively. There was a weak
positive association between fortified milk intake and body weight at the
end of the study (r¼ .247, P¼ .012). Consumption of the fortified milk was
positively associated with dietary vitamin D (r¼ .573, P< .001), calcium
(r¼ .248, P¼ .006), and folate (r¼ .162, P¼ .051) intakes over the study
period.
Energy and Nutrient Intakes
Complete data on energy and nutrient intakes were available for 104 partici-
pants at baseline and at the intervention time points (Table 2). The baseline
dietary intake was compared with the average daily intake measured on
available participants on two occasions during the six-month intervention
period.
Vitamin D
The median dietary vitamin D intakes increased six-fold over the study
period (Table 2) to nearly 70% of the recommended adequate intake (AI,
15mg). No participant met the vitamin D AI at the beginning of the study;
however 25% (n¼ 26) met it by the end of the six months. Those who met
the AI consumed an average of 289 36ml fortified milk, corresponding to
1436 58mg calcium and 19.9 1.2mg vitamin D. No participant exceeded
the upper intake limit (UL) for vitamin D (>80 mg) at any time point (even
after accounting for those consuming vitamin D supplements: range:
5–25 mg vitamin D=day).
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Calcium
There was no change in dietary calcium intakes over the study period
(Table 2); however dietary calcium intake (adjusted for energy intake:
calcium density, mg=MJ) was higher over the study period compared with
baseline (161 5mg=MJ vs. 142 4mg=MJ, P< .001), and the amount of
calcium derived from discretionary fortified milk intake (tea=coffee, cereal,
milk drinks) were also higher (Table 2). Participants consuming greater than
160ml milk per day (the median intake) had a 297mg greater calcium intake
over the study period (Table 3). No participant exceeded the calcium UL
(2500mg) at the beginning or during the intervention.
Folate
Mean dietary folate intakes increased over the study period (Table 2),
exceeding the 320 mg EAR. No participant reached the UL for folate
(1000 mg) at the beginning of the study; however seven exceeded it by
10% at the end (mean (SD) 1103 (21mg). The mean (SD) intake of folate from
the fortified milk was 120 mg (127 mg) (range: 0–900mg) and from nutritional
drink supplements (n¼ 7) was 123 (104mg) (range: 0–887mg).
Serum Indices
The mean (SEM) serum concentration of 25(OH)D increased by 23
2 nmol=L (83 (107%) (P< .001), yet most participants remained in the insuffi-
cient range (25–50 nmol=L) at the end of the study (13% 25 nmol=L; 45%
25–50 nmol=L, Table 1). Serum 25(OH)D insufficiency (<50 nmol=L) was
reduced from 90 participants (84%) at baseline to 65 participants (61%) at
TABLE 3 Differences in Mean (SEM) Dietary Intakes and Serum Levels of Vitamin D,
Calcium, and Folate Between Those With Fortified Milk Consumption of  or > Median
Intake of Milk (160ml=d) Over the Study Period
160ml fortified
milk intake (n¼ 49)
>160ml fortified
milk intake (n¼ 54)
Serum
25(OH)D (nmol=L) 36.9 2.4 53.1 2.4y
Calcium (mmol=L)a 2.3 0.0 2.4 0.0
Folate (mmol=L) 20.0 2.1 22.0 1.6
Diet
Vitamin D (mg) 5.7 0.7 14.5 1.3y
Calcium (mg) 791 61 1088 58y
Folate (mg) 369 35 465 28y
aSerum value corrected for albumin.
P< .05.
yP .001 vs.<160ml fortified milk intake.
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the end of the study (P¼ .002). In those who consumed greater than the
median intake of fortified milk (160ml), the mean serum 25(OH)D levels
increased into the adequate range (Table 3). In this group 23 participants
(43%) would be classified as vitamin D deficient (serum 25(OH)D<
50 nmol=L) compared with 81% of those who consumed less than 160ml
milk (P< .001). Consumption of more than 160ml fortified milk reduced
serum PTH concentrations by 24% compared with those who consumed less
than 160ml fortified milk (Figure 1).
Provision of fortified milk increased mean (SEM) serum folate concen-
trations by 45 (89%) (P¼ .030) (median [IQR] 22 [85]%), with median levels
remaining in the normal range throughout the study (Table 1). At baseline,
12 and 15 participants were deficient (<5 nmol=L) or had borderline folate
levels (5–7 nmol=L), respectively, whereas only 8 and 5 participants were defi-
cient or borderline at the end of the study (P< .001). At baseline, 12 and 14
participants, respectively, were deficient (<150 pmol=L) or had borderline
(150–200 pmol=L) vitamin B12 concentrations, compared with 14 participants
and 11 participants, respectively, at the end of the study (P< .001).
At baseline, four participants had high serum calcium concentrations
(corrected for albumin;>2.65mmol=L). At the end of the study, seven
participants’ levels increased to above this and four participants fell below
2.65mmol=L (who were previously above this level).
After adjustment for (log) baseline serum 25(OH)D, there was an
association between the absolute changes in dietary vitamin D intake and
FIGURE 1 Mean (SEM) percent changes in serum concentrations of target nutrients
and PTH for those consuming  or > median intake of milk (160ml=day) over the study
period.
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serum 25(OH)D (r¼ .261, P¼ .004), and the absolute change in serum
25(OH)D correlated with the (log) average daily fortified milk intake
(r¼ .399, P< .001). When adjusting for (log) baseline serum folate, there
was an association between the (log) absolute changes in total dietary folate
intake and serum folate (r¼ .244, P¼ .005), but not with fortified milk intake.
There was no difference between baseline and end of study serum CTX
(bone resorption marker) concentrations (n¼ 100, 0.66 0.04 ng=ml vs.
0.69 0.05 ng=ml, P¼ .404). There was a trend for those in LLC to have a
lower CTX value at the end of the study, indicating lower bone resorption,
compared with those in HLC (0.55 0.06 ng=ml (n¼ 36) vs. 0.77 0.07 ng=ml
(n¼ 64), P¼ .060). There was no difference between the percent or absolute
changes between these groups or between males and females.
There was no difference between baseline and end of study serum
terminal PINP (bone formation marker) concentrations (n¼ 100, 50.0
3.0 mg=L vs. 48.0 3.0mg=L, P¼ .113). There were no associations between
CTX and PINP with fortified milk intake, serum 25(OH)D, or PTH.
Heel Ultrasound
Over the intervention period, there was a mean (SD) decline in heel ultra-
sound (n¼ 88, 3.38 (15.17) dB=MHz, (0.3%), P¼ .048). There was a
weak, positive association between (log) fortified milk intake and (log)
QUS (n¼ 88, r¼ .154, P¼ .076). There was no association between serum
25(OH)D and heel ultrasound.
Falls Incidence
During the intervention period, 43 participants fell, with the median [IQR]
number of falls being 0 [2] falls. There were no associations between those
who fell with age, body weight, heel ultrasound, fortified milk intake, serum
indices, or functional markers (data not shown).
Timed Up and Go and Hand Grip Strength
There was a trend for a slower TUG time (n¼ 50, mean (SD) 2.56 (15.6)
seconds, P¼ .065) over the intervention period. There was no difference
between hand grip strength (HGS) when assessed at the beginning
(n¼ 77, 17.4 0.9 kg) or at the end of the study (17.6 0.8 kg, P¼ .693).
There were no associations between fortified milk intake and TUG or HGS.
Acceptability Questionnaire
To assess the acceptability of the milk, senior staff (i.e., eight unit nurse man-
agers: 100% of those approached; seven personal care assistants (100% of
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those approached); and five pantry staff (63% of those approached) who
were actively involved in the provision of milk were approached by a
research assistant to complete the acceptability questionnaire. Twenty six
participants (13 LLC and 13 HLC: 25% of study sample) also completed a
questionnaire relating to the acceptability of the fortified milk.
Overall, the majority of staff felt the participants were very satisfied with
consuming the fortified milk. Comments concerning the positive aspects of
the milk by both staff and participants included the liking of its taste
(n¼ 7). Negative comments noted by staff included the extra work required
in remembering to serve it and to whom (n¼ 2). Sixty seven percent of staff
and 92% of participants believed it would not be difficult to continue with
only using fortified milk, with 77% of LLC participants and 83% of HLC
participants stating it would not be difficult to consume more than 160ml
milk=day.
DISCUSSION
Our study was the first to fortify the milk supply with calcium, folate, and
vitamin D in a group of Australian aged care residents. Following six months
of fortified milk consumption, dietary intakes of vitamin D increased by
six-fold and consumption of 160ml=day (approximately 7.5mg vitamin D)
raised serum 25(OH)D concentrations into the adequate range (> 50nmol=L),
with 57% (n¼ 31) of participants no longer deficient (<50nmol=L). Previously,
in a study of older residents in Ireland, vitamin D–fortified milk, which was one
fifth of the level used in our study (1mg=100ml), increased serum 25(OH)D
from 6nmol=L to 37nmol=L after three months (26). A recent review, however,
has suggested that serum 25(OH)D levels of at least 75mmol=L may be
required to maintain bone density and prevent falls and fractures (34). A recent
meta-analysis of vitamin D supplementation in elderly subjects 50 years or
older indicated that vitamin D doses less than 10mg had no beneficial effect
on fracture, whereas vitamin D doses above 17.5mg appeared sufficient to
reduce fractures, with serum levels raised to a mean 74nmol=L (35). A subse-
quent meta-analysis also revealed that vitamin D (17.5–20mg) plus calcium
(500–1200mg) supplementation, or simply supplementing with calcium
only (1200mg=day) resulted in a reduction in fracture (25). We found
those consuming 160ml milk or more had a mean vitamin D and calcium
intake of approximately 15mg and 1000mg, respectively, with a mean serum
25(OH)D of 53nmol=L. Accordingly, the volume of fortified milk consumed
in our study would be unlikely to reduce fracture risk because the dose of
vitamin D is too low. However, we did find that consumption of at least
160mls=day of fortified milk favorably reduced serum PTH concentrations.
Secondary hyperparathyroidism has been proposed as the principal mech-
anism whereby vitamin D deficiency could contribute to the pathogenesis of
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hip fractures; an elevated plasma PTH concentration also is a recognized
risk factor for osteoporosis (36). The reduction in PTH following fortified
milk consumption of 160mls or more therefore could contribute in the long-
term to a reduction in fracture risk.
Rather than a high dose supplement, we used milk, which being a
whole food, contains a range of macro- and micronutrients that are likely
to be beneficial to bone health (e.g., protein, phosphorous, potassium,
magnesium, and zinc), and this may actually exert a greater effect than that
seen with tablet supplementation (37). Provision of consistent, low supple-
mental doses, within a nutritious, well-accepted food product may result in
a greater beneficial effect on fracture risk in the long-term than that is
achieved through provision of daily supplements of calcium.
We found no associations between fortifiedmilk intake and bonemarkers;
however we had limited power to detect any effects on these markers. Supple-
mentation with larger doses of calcium (500mg) and vitamin D (10mg) has
been found to reduce CTX concentrations in elderly women (38); and in
25(OH)D deficient (<25nmol=L) post-menopausal women, calcium (500mg)
and vitamin D (10mg) increased bone density by 3% (39). In our more frail
population, larger doses may be necessary to reduce bone loss.
Half of our elderly participants consumed at least 160mls of fortified
milk per day, with an average daily calcium intake of 1000mg. However,
the remaining half consumed less than this, indicating the difficulties in
consuming this relatively small volume of milk as a drink, in beverages or
with cereal, on a daily basis. It is likely that a higher calcium intake, closer
to recommended intake levels, could be achieved if fortified milk replaced
all milk that is used in cooking, desserts, and soups, as well as the discretion-
ary milk consumed.
No participant reached the UL for vitamin D, even when supplement
doses were included. The UL limit for vitamin D has been criticized for being
too low (40). However, fortification of milk with a higher concentration of
vitamin Dwould not be recommended at this point as this would result in con-
sumptions greater than the UL for vitamin D, which would be difficult to
implement on larger scale as intakes would exceed the current UL. Although
a few participants reached the estimated UL for calcium, at this level, there is
little evidence to link this with any adverse effects on health. Seven partici-
pants reached the UL for folate and high folate intake have been associated
with impaired cognitive function in older people who also have low levels
of vitamin B12 (41). Although some participants had deficient or borderline
serum vitamin B12 levels, these levels were not in combination with high folate
(>59 nmol=L).
Staff perceived that the elderly residents were satisfied with consuming
the fortified milk, and the residents confirmed this view. Comments made
also included there would be few difficulties with using the fortified milk
in place of usual full cream milk. A strategy to increase the fortified milk
Calcium, Folate, and Vitamin D3–Fortified Milk in Aged Care 249
D
o
w
n
lo
ad
ed
 B
y:
 [
De
ak
in
 U
ni
ve
rs
it
y]
 A
t:
 0
3:
57
 2
1 
Ja
nu
ar
y 
20
10
intake for all residents could be the addition of fortified milk in either a dried
or fluid form in dishes such as soup and custard where regular milk is
generally used. This would potentially allow a greater number of residents
to significantly increase their dietary calcium.
Limitations to this study include the lack of control group. We have,
however, previously reported 17% and 2% reductions in serum 25(OH)D
and folate respectively, over six months at the same time of year, in a placebo
group among a similar older population (24). The current study therefore
supports our conclusion that provision of fortified milk increased serum
25(OH)D and folate, compared with when no fortified milk is consumed.
We acknowledge that the timeframe was probably too short to identify a
change in bone quality (using heel ultrasound), however we have demon-
strated an effect on bone quality with multivitamin supplementation over
six months (24). The strengths of this study included the relatively long inter-
vention period to improve nutritional status, the measurement of nutritional
status before and after the provision of fortified milk, and that we were able
to estimate the amount of milk consumed on an individual resident basis and
assess the fortified milk acceptability.
In conclusion, although vitamin D status improved, most participants
did not reach the estimated optimal level of 75 nmol=L of serum
25(OH)D, which has been found to reduce falls and fractures. It would be
recommended that vitamin D supplements be provided to this group where
there is limited access to sunlight to ensure vitamin D sufficiency. Provision
of larger doses administered 3 to 4 times=year would reduce any subject bur-
den and be more acceptable than daily doses. As vitamin D is stored in fat,
this supplementation scheme may be an option for vitamin D but not for cal-
cium. Calcium-fortified products provide an acceptable alternative to calcium
supplements in this population and may in the long-term assist in reducing
fracture by maintaining adequate calcium intake. It is also worth noting that
the majority of the trials that have demonstrated a benefit with vitamin D
supplementation were combined with calcium (36).
It should also be acknowledged that the amount of milk consumed var-
ies widely within this population and that only 50% of this group consumed
at least 160mls=day. Further studies are required assessing whether vitamin
D sufficiency, achieved through supplementation combined with the provi-
sion of calcium fortified milk used in cooking plus beverages and cereals,
can, in the long-term, reduce falls and fractures.
TAKE AWAY POINTS
. Six months of fortified milk consumption increased dietary intakes of vita-
min D and increased serum vitamin D levels, resulting in a favorable
reduction in serum PTH.
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. In those who consumed at least 160mls (median intake) milk per day, 43%
were still classified as vitamin D deficient (serum 25(OH)D< 50 nmol=L);
therefore the use of this milk was not sufficient to ensure adequate levels
of serum vitamin D for this population.
. Vitamin D supplements would be recommended for this group to ensure
25(OH)D sufficiency. Provision of larger doses administered 3 to 4 times=
year may be effective and probably more acceptable than daily doses. In
addition the use of a range of calcium-fortified products could provide an
acceptable alternative to calcium supplements in this population and
assist in reducing rates of fracture by maintaining adequate calcium
intake.
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